Radioimmunoassay of beta2-microglobulin

Area of Science:

• Biochemistry
• Clinical Chemistry
• Immunology

Background:

• Beta2-microglobulin (B2M) is a protein found on the surface of most nucleated cells.
• Elevated B2M levels are associated with various conditions, including kidney disease and certain cancers.
• Accurate quantification of B2M is crucial for diagnosis and monitoring.

Purpose of the Study:

• To describe a novel radioimmunoassay (RIA) for the accurate measurement of beta2-microglobulin.
• To establish reference ranges for B2M in serum and urine of healthy individuals.
• To validate the assay's performance characteristics.

Main Methods:

• Development of a radioimmunoassay utilizing polyethylene glycol 6000 for antigen-antibody complex precipitation.
• Assay validation including determination of assay range, detection limit, and coefficient of variation.
• Measurement of B2M concentrations in serum and 24-hour urine samples from healthy human subjects.

Main Results:

• The developed RIA provides B2M quantitation within a 5-hour timeframe.
• Mean serum B2M concentration in healthy adults was 125 nmol/l (range: 49-190 nmol/l).
• Mean 24-hour urinary B2M excretion was 12.9 nmol in men and 5.5 nmol in women.
• The assay demonstrated a wide assay range (0.23-19.40 nmol/l) and a low detection limit (0.042 nmol/l).
• Coefficients of variation were 8.1% and 9.0% for serum B2M concentrations of 8.14 and 1.92 nmol/l, respectively.

Conclusions:

• The described radioimmunoassay is a reliable and efficient method for quantifying beta2-microglobulin in biological samples.
• The established reference ranges provide valuable data for interpreting B2M levels in clinical settings.
• This assay facilitates the diagnosis and management of conditions associated with altered B2M metabolism.